Stay updated on Pembrolizumab in Thymic Tumors Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Thymic Tumors Clinical Trial page.

Latest updates to the Pembrolizumab in Thymic Tumors Clinical Trial page
- CheckyesterdayChange DetectedSite maintenance notes show Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure (previous Revision: v3.3.2); no study details or data are affected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedPublications section now notes that entries are automatically filled from PubMed and displays Revision: v3.3.2. The previous wording about PubMed-derived publications has been replaced with updated phrasing.SummaryDifference0.1%

- Check37 days agoChange DetectedRemoved the general operating status notice about government funding and NIH operations. This does not affect the study's core details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check51 days agoChange DetectedCosmetic and layout changes are observed, with no changes to core study data such as title, status, enrollment, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check80 days agoChange Detected- Updated the page to v3.2.0 and added a government-operational-status notice clarifying potential delays and open status of NIH Clinical Center. - Removed the previous version tag v3.1.0.SummaryDifference4%

- Check87 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Thymic Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Thymic Tumors Clinical Trial page.